Stanislas Malmezat

Stanislas Malmezat is Chief Financial Officer of Kainova Therapeutics. He joined the company in 2018 to structure and develop the financial and legal department as well as to support the CEO in corporate strategic development.

Before joining the organization, Stanislas built extensive operational experience over more than 6 years as CFO at Rarecells Diagnostics and later at CleveXel Pharma. Earlier in his career, he gained solid expertise in corporate finance, first within a French venture capital fund specialized in biotechnology, then as consultant in the corporate restructuring & transaction services department at Ernst & Young, and subsequently at Duff & Phelps in Paris, where he worked on merger and acquisition operations. He began his career in the pharmaceutical industry as a product manager at Johnson & Johnson.

Stanislas holds a PhD in pharmacy and is a graduate from the ESSEC Business School in Paris, France.